Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation – Data from RACE 3-Reference-Cited by-同舟云学术

Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation – Data from RACE 3

Published:2020-08 Issue: Volume:226 Page:235-239
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Nguyen Bao-Oanh,Rienstra Michiel,Hobbelt Anne H.,Tijssen Jan G.P.,Smit Marcelle D.,Tieleman Robert G.,Geelhoed Bastiaan,Van Veldhuisen Dirk J.,Crijns Harry J.G.M.,Van Gelder Isabelle C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–962.

2. Catheter ablation for atrial fibrillation with heart failure;Marrouche;N Engl J Med,2018

3. Atrial remodeling and atrial fibrillation: Recent advances and translational perspectives;Nattel;J Am Coll Cardiol,2014

4. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: The ARREST-AF cohort study;Pathak;J Am Coll Cardiol,2014

5. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis;Healey;J Am Coll Cardiol,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Catheter ablation versus medical therapy for atrial fibrillation in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis;Heart Rhythm;2024-09

2. A comprehensive meta-analysis comparing radiofrequency ablation versus pharmacological therapy for the treatment of atrial fibrillation in patients with heart failure;International Journal of Cardiology;2023-04

3. Atrial Fibrillation: Is Rhythm Control Required, and If So, How, and What Is the Internist's Role?;The American Journal of Medicine;2022-08

4. Dapagliflozin effect on heart failure with prevalent or new‐onset atrial fibrillation;European Journal of Heart Failure;2022-02-13

5. Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report;Journal of the American Heart Association;2021-08-17